HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

496.758

-15.630-3.05%

Number of Gainers:6

Number of Losers:25

Number of Flat:2

PE:- -

High:512.373

Open:512.373

Low:495.812

Close:512.388

Volume:95.41M

Turnover:2.18B

Market Cap:315.16B

Float Cap:281.17B

Loading ...

ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis

Ascletis Pharma - Initiates U.S. Phase I Study for Asc36 Oral Tablets for Obesity

THOMSON REUTERS

Consolidation at the Base Meets Trend Rebound: When Will Kintor Pharma-B Hit the Key Turning Point for a Valuation Recovery?

Nanxin Pharmaceutical Receives Penalty for Disclosure Violations, Affected Investors May Seek Compensation

InnoCare Gets First Half of Remaining Stake Bought in Subsidiary

MT Newswires Live

HK Market Alert: Biocytogen-B (02315) Surges Over 10% in Afternoon Trade Following Exclusive Licensing Agreement with Qilu Pharmaceutical

Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D

Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial Milestones

Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication

China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily

Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum

Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7

Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each

SinoMab BioScience Held Shareholder Meeting, Disposal Resolution Drew 100% Support

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK1574/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":496.75812,"timestamp":1789027721934,"preClose":512.3882,"halted":0,"volume":95412163,"delay":0,"changeRate":-0.030504,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-15.630066,"latestTime":"09-10 16:00:00","open":512.3731,"high":512.3731,"low":495.81204,"amount":2180840440,"amplitude":0.032321,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":3.809281,"peRate":169.439728,"turnoverRate":0.003564,"increases":5,"decrements":26,"flats":1,"marketCap":315159581920,"floatMarketCap":281174468760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":512.3731,"amplitude":0.032321,"preClose":512.3882,"low":495.81204,"pbRate":"3.809281","latestPrice":496.75812,"volume":95412163,"delay":0,"open":512.3731,"prevYearClose":556.26263,"prevWeekClose":532.025,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":515.473,"twentyDayClose":536.134,"sixtyDayClose":437.19,"secType":"PLATE","market":"HK","turnoverRate":0.003564,"peRate":169.439728,"marketCap":315159581920,"floatMarketCap":281174468760,"timestamp":1789027721934,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":25,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164928784","title":"ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis","url":"https://stock-news.laohu8.com/highlight/detail?id=1164928784","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164928784?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:06","pubTimestamp":1788861983,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) has announced the initiation of its Phase I clinical study in the United States for ASC36, an oral amylin receptor agonist peptide designed to treat obesity, following...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1515","BK1161","BK1574","BK1191","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665932180","title":"Ascletis Pharma - Initiates U.S. Phase I Study for Asc36 Oral Tablets for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665932180?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:01","pubTimestamp":1788861676,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150107003","title":"Consolidation at the Base Meets Trend Rebound: When Will Kintor Pharma-B Hit the Key Turning Point for a Valuation Recovery?","url":"https://stock-news.laohu8.com/highlight/detail?id=1150107003","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150107003?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:48","pubTimestamp":1788857312,"startTime":"0","endTime":"0","summary":"On the morning of September 7, KINTOR PHARMA-B (09939) announced that its human long-term safety trial for KT-939, a novel and highly effective tyrosinase inhibitor developed in-house to suppress...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101281013","title":"Nanxin Pharmaceutical Receives Penalty for Disclosure Violations, Affected Investors May Seek Compensation","url":"https://stock-news.laohu8.com/highlight/detail?id=1101281013","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101281013?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:31","pubTimestamp":1788852662,"startTime":"0","endTime":"0","summary":"Nanxin Pharmaceutical has been found to have disclosed inaccurate financial data in its annual report. On August 13, 2026, the company officially received the Administrative Penalty Decision issued...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665476053","title":"InnoCare Gets First Half of Remaining Stake Bought in Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2665476053","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665476053?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:15","pubTimestamp":1788848135,"startTime":"0","endTime":"0","summary":"InnoCare Pharma  received the first half of the 7% stake of Guangzhou InnoCare Pharma Technology, according to a Shanghai bourse filing on Tuesday.Guangzhou InnoCare completed the changes in its industry and commerce registration after its parent received its 3.5% stake.InnoCare bought the remaining 7% of Guangzhou InnoCare for 476.3 million yuan in August.The pharmaceutical company's shares slipped 1% during the afternoon trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK1161","09969","BK1574","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170187220","title":"HK Market Alert: Biocytogen-B (02315) Surges Over 10% in Afternoon Trade Following Exclusive Licensing Agreement with Qilu Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1170187220","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170187220?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:00","pubTimestamp":1788847256,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) saw its shares jump more than 10% in the afternoon session, last trading up 8.71% at HK$63 with turnover reaching HK$129 million.According to the company's official WeChat...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK4585","BK1574","VXUS","BK4588","BK1161","BK1191","02315","KCAI","BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134077786","title":"Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1134077786","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134077786?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:50","pubTimestamp":1788846618,"startTime":"0","endTime":"0","summary":"CRO-related stocks extended their upward momentum into the afternoon session, with Genscript Bio (01548) surging 10.71% to HK$34.32, Asymchem (06821) climbing 8.5% to HK$142.90, Tigermed (03347)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1191","ARTY","03759","BK1574","AGIX","BK1141","BK1583","HK0000306701.USD","LRND","BME","VTHR","AIPO","QTOC","HK0000320223.HKD","06821","01477","HK0000306685.HKD","KCAI","01548","BK4588","VXUS","HK0000320264.USD","BK4585","CHAT","03347","JHMH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188251172","title":"Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1188251172","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188251172?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:44","pubTimestamp":1788846259,"startTime":"0","endTime":"0","summary":"Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial MilestonesCSTONE PHARMA-B (02616) witnessed a strong afternoon rally on Tuesday, climbing more than 6%...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","BK4585","FLHK","BK1161","161027","BK1574","KCAI","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167357330","title":"Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1167357330","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167357330?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:56","pubTimestamp":1788839775,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) saw its share price climb more than 5% during morning trading on Wednesday. As of the time of writing, the stock was up 4.73% to HK$32.78, with trading turnover reaching HK$151...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","01952","BK4585","IPOS","VXUS","BK1583","BK1161","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106413707","title":"China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily","url":"https://stock-news.laohu8.com/highlight/detail?id=1106413707","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106413707?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:34","pubTimestamp":1788838468,"startTime":"0","endTime":"0","summary":"China Securities has released a research note indicating that the medical device sector maintained its revenue growth trajectory in Q2, with quarterly profit growth turning positive for the first...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","159883","BK1583","IEIH","PTH","HART","601066","MEDX","GDOC","LGHT","BK1574","LNGR","MDEV","BK0276","RSPH","AGNG","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183000307","title":"Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1183000307","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183000307?lang=en_us&edition=fundamental","pubTime":"2026-09-08 10:22","pubTimestamp":1788834140,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) shares climbed more than 6% in Monday's session, trading up 6.02% at HK$28.52 as of the time of writing. The stock recorded a turnover of HK$6.452 million with a volume ratio of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLHK","BK4585","09637","BK4588","159938","BK1161","HSCI","BK1515","BK1574","09939","KCAI","BK1191","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169256250","title":"Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors","url":"https://stock-news.laohu8.com/highlight/detail?id=1169256250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169256250?lang=en_us&edition=fundamental","pubTime":"2026-09-07 22:10","pubTimestamp":1788790245,"startTime":"0","endTime":"0","summary":"Sell-side research has witnessed a notable career pivot as a healthcare-focused analyst has transitioned to covering the electronics sector, marking a significant departure from their academic and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","KCE","09939","BK1515","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311564","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311564","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311564?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:12","pubTimestamp":1788783177,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share buyback cancellationZylox-Tonbridge repurchased 53,500 H shares on Sept. 7, 2026 for holding as treasury shares; no shares were cancelled","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL100F5h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02190","BK1100","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106718626","title":"Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718626","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106718626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:51","pubTimestamp":1788781895,"startTime":"0","endTime":"0","summary":"Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488) has disclosed its intention to participate in a collective earnings presentation tailored for the innovative drug sector on the STAR Market,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","KSTR","MEDX","BK0262","BK1161","688488","BK1574","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135498525","title":"Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1135498525","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135498525?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:21","pubTimestamp":1788780087,"startTime":"0","endTime":"0","summary":"More than two years have passed since the failed acquisition, and the 60% equity stake in Jinan Pingjia is once again on the property rights trading market, now with a minimum listing price of 24...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0209","301017","09939","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","09995","IBBQ","LU1064130708.USD","06978","159992","LNGR","BK1583","BK0239","LU1969619763.USD","LU2328871848.SGD","LU2148510915.USD","LU1064131003.USD","LU2488822045.USD","KSTR","MEDX","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179966506","title":"ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1179966506","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179966506?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:20","pubTimestamp":1788776414,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that on September 7, 2026, it spent HK$989,200 to repurchase 115,000 shares.The buyback reflects the company's ongoing capital management strategy, with the repurchased...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315451","title":"Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315451","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315451?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:16","pubTimestamp":1788776202,"startTime":"0","endTime":"0","summary":"Alphamab Oncology files HKEX next-day return disclosing share repurchase at HKD 8.6 eachAlphamab Oncology repurchased 115,000 ordinary shares on Sept. 7, holding all as treasury shares.Buyback price r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL4b0tJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665200318","title":"SinoMab BioScience Held Shareholder Meeting, Disposal Resolution Drew 100% Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2665200318","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665200318?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:07","pubTimestamp":1788772023,"startTime":"0","endTime":"0","summary":"SinoMab BioScience held shareholder meeting, disposal resolution drew 100% supportSinoMab BioScience held an extraordinary general meeting on Sept. 7, 2026.Shareholders adopted a resolution to confirm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL9Tlkd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182662414","title":"Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future","url":"https://stock-news.laohu8.com/highlight/detail?id=1182662414","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182662414?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:21","pubTimestamp":1788769307,"startTime":"0","endTime":"0","summary":"Shares of Zhejiang Anglikang Pharmaceutical Co.,Ltd. (002940.SZ) briefly hit the daily limit up on September 4th, buoyed by news of medical insurance negotiations and the launch of commercial...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159992","BK0239","LNGR","06978","IBBQ","MEDX","BK1574","002940"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":3,"totalSize":274,"code":"91000000","status":"200"}]}}